Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on Top Healthcare Stocks: Amgen (AMGN), Alector (ALEC)

Tipranks - Tipranks - Tue Apr 7, 12:02PM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Amgen (AMGN) and Alector (ALEC) with bullish sentiments.

Easter Sale - 70% Off TipRanks

Amgen (AMGN)

William Blair analyst Matt Phipps maintained a Buy rating on Amgen today. The company’s shares closed last Monday at $343.30, close to its 52-week high of $346.85.

According to TipRanks.com, Phipps is a 4-star analyst with an average return of 4.9% and a 43.8% success rate. Phipps covers the Healthcare sector, focusing on stocks such as NewAmsterdam Pharma Company, Janux Therapeutics Inc, and Ionis Pharmaceuticals. ;'>

Currently, the analyst consensus on Amgen is a Moderate Buy with an average price target of $369.16, which is a 6.9% upside from current levels. In a report issued on March 24, Scotiabank also maintained a Buy rating on the stock with a $385.00 price target.

See today’s best-performing stocks on TipRanks >>

Alector (ALEC)

BTIG analyst Thomas Shrader maintained a Buy rating on Alector on April 2 and set a price target of $6.00. The company’s shares closed last Monday at $2.45.

According to TipRanks.com, Shrader is a 4-star analyst with an average return of 6.1% and a 39.9% success rate. Shrader covers the Healthcare sector, focusing on stocks such as Coya Therapeutics, Inc., Alto Neuroscience, Inc., and Acumen Pharmaceuticals. ;'>

Alector has an analyst consensus of Hold, with a price target consensus of $2.88.

Read More on AMGN:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).